Physician profile
Lindsey Cossio
NPI 1841659216
$411.28
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $411.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $156.23 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.26 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $48.25 | 2021 | |
| Vifor Pharma, INC. | $45.28 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $26.91 | 2021 | |
| Akebia Therapeutics INC | $23.06 | 2021 | |
| Recordati_rare_diseases_inc. | $19.53 | 2021 | |
| Opko Pharmaceuticals, LLC | $16.16 | 2021 | |
| Fresenius USA Marketing, INC. | $15.60 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Cossio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.